Breast Cancer Clinical Trial
Official title:
A Comparison Study of Breast Tomosynthesis Images Reconstructed at 1 Millimeter and 5 Millimeter Slice Thicknesses
Early diagnosis is one of the most important factors in the survival of patients diagnosed
with breast cancer. To aid in the early detection of breast cancer, a new technology, called
tomosynthesis imaging is being developed. The idea behind tomosynthesis imaging is to "look"
at the breast from different points of view by obtaining x-ray flat images from different
angles while the breast does not move, and then mathematically combine these flat images
into a three-dimensional image. The benefit of these three dimensional images is that the
radiologist can look at the different tissues of the breast in their real positions, as
opposed to all the tissues being "flattened" into a flat image, like that of a normal
mammogram. Since tomosynthesis images of the breast show the tissues in their real position,
the radiologist should be able to more easily find a tumor and also be able to reduce the
number of time he or she thinks there is a tumor present when in reality there is not one
there.
Before this new technology can be used in the clinic routinely, it is necessary to perform a
large number of studies to find the optimal way to use it. In this study, the investigators
are aiming to find how thick the slices or layers representing the breast should be in the
image when shown to the radiologist. The difference between these two thicknesses in how
useful the images are to the radiologist could be important. The investigators are trying to
determine if slicing the image of the breast into thicker slices will make the job of the
radiologist easier or not when deciding to recommend or not a biopsy (laboratory analysis)
of what the previous mammogram found. To find the answer to this question, the investigators
will image patients with their tomosynthesis machine and look at the tomosynthesis images
with the thin and thick slices. The radiologists that read each image will decide if they
would have recommended the patient to get a biopsy based only in each of these images. The
recommendations based on the images with thin slices and the recommendations based on the
images with thick slices will be compared with what was actually recommended using the
standard clinical tests. The investigators hope to find that the thicker slices help more
than the thinner slices when trying to decide if biopsy is needed or not.
Early diagnosis is one of the most important factors in the survival of patients diagnosed
with breast cancer. To aid in the early detection of breast cancer, a new technology, called
tomosynthesis imaging is being developed. The idea behind tomosynthesis imaging is to "look"
at the breast from different points of view by obtaining x-ray flat images from different
angles while the breast does not move, and then mathematically combine these flat images
into a three-dimensional image. The benefit of these three dimensional images is that the
radiologist can look at the different tissues of the breast in their real positions, as
opposed to all the tissues being "flattened" into a flat image, like that of a normal
mammogram. The flat images in mammograms bring about the possibility that normal healthy
tissue sometimes covers up malignant tumors, making them harder, and sometimes impossible,
for the physician to see. In addition, this "flattening" sometimes generates what appears to
be suspicious tissue, but is in reality a superposition of normal healthy tissue. This
effect results in performing an increased number of biopsies that end up being negative for
breast cancer. Since tomosynthesis images of the breast show the tissues in their real
position, these effects can be avoided. It has already been shown by various research labs,
including ours, that this kind of imaging does in fact result in better visualization of
lesions compared to conventional two-dimensional imaging, even without performing
tomosynthesis under ideal conditions.
For tomosynthesis to reach its full potential, it is necessary to perform a large number of
studies to find the optimal way to acquire the tomosynthesis images and the optimal way to
mathematically combine these images to get the three dimensional image. In this study, we
are aiming to find if the resulting three dimensional image should be divided into slices or
layers each representing 1 millimeter (less than one 16th of an inch) of the breast or 5
millimeters (one 5th of an inch) of the breast. The difference between these two thicknesses
in how useful the images are to the radiologist could be important. Up to now, tomosynthesis
imaging has been performed with 1 millimeter slices, but there has been no scientific study
to prove that this is the best slice thickness. We will try to determine if slicing the
image of the breast into thicker slices will make the job of the radiologist easier or not
when deciding to recommend or not a biopsy (laboratory analysis) of what the previous
mammogram found. To find the answer to this question, we will image patients with our
tomosynthesis machine and look at the tomosynthesis images with the thin and thick slices.
The radiologists that read each image will decide if they would have recommended the patient
to get a biopsy based only in each of these images. The recommendations based on the images
with thin slices and the recommendations based on the images with thick slices will be
compared with what was actually recommended using the standard clinical tests. We hope to
show that the images with the thick slices will do as well if not better than those with the
thin slices. Even if the thick slices only do as well as the thin slices, this will show
that creating images with thicker slices is better, since these images can be read faster by
the radiologist.
;
Observational Model: Case Control, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |